ArticleBioconjugate chemistry2019

Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes.

Neha Nandedkar-Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.